166
Views
13
CrossRef citations to date
0
Altmetric
Articles

Nature-derived epigallocatechin gallate/duck’s feet collagen/hydroxyapatite composite sponges for enhanced bone tissue regeneration

, , , , , , & show all
Pages 984-996 | Received 11 Apr 2017, Accepted 23 Nov 2017, Published online: 20 Dec 2017

References

  • Fishero BA, Kohli N, Das A, et al. Current concepts of bone tissue engineering for craniofacial bone defect repair. Craniomaxillofac Trauma Reconstr. 2015;8:23–30.
  • Azami M, Moosavifar MJ, Baheiraei N, et al. Preparation of a biomimetic nanocomposite scaffold for bone tissue engineering via mineralization of gelatin hydrogel and study of mineral transformation in simulated body fluid. J Biomed Mater Res A. 2012;100:1347–1355.10.1002/jbm.a.v100a.5
  • Cho CH, Lee SB. Biodegradable collagen matrix (Ologen) implant and conjunctival autograft for scleral necrosis after pterygium excision: two case reports. BMC Ophthalmol. 2016;15;140.
  • Bitar KN, Zakhem E. Design strategies of biodegradable scaffolds for tissue regeneration. Biomed Eng Comput Biol. 2016;6:13–20.
  • Kook YJ, Lee DH, Song JE, et al. Osteogenesis evaluation of duck’s feet-derived collagen/hydroxyapatite sponges immersed in dexamethasone. Biomater Res. 2017;21:2.10.1186/s40824-017-0088-4
  • Kim SH, Park HS, Lee OJ. Fabrication of duck’s feet collagen-silk hybrid biomaterial for tissue engineering. Int J Biol Macromol. 2016;85:442–450.10.1016/j.ijbiomac.2015.12.086
  • Pawlaczyk I, Czerchawski L, Kanska J, et al. An acidic glycoconjugate from Lythrum salicaria L. with controversial effects on haemostasis. J Ethnopharmacol. 2010;131:63–69.10.1016/j.jep.2010.06.001
  • Quinlan E, Lopez-Noriega A, Thompson E, et al. Development of collagen-hydroxyapatite scaffolds incorporating PLGA and alginate microparticles for the controlled delivery of rhBMP-2 for bone tissue engineering. J Control Release. 2015;198:71–79.10.1016/j.jconrel.2014.11.021
  • Peter B, Bosze S, Horvath R. Biophysical characteristics of proteins and living cells exposed to the green tea polyphenol epigallocatechin-3-gallate (EGCg): review of recent advances from molecular mechanisms to nanomedicine and clinical trials. Eur Biophys J. 2017;46:1–24.10.1007/s00249-016-1141-2
  • Wang WL, Sheu SY, Chen YS, et al. Enhanced bone tissue regeneration by porous gelatin composites loaded with the Chinese herbal decoction Danggui Buxue Tang. PLoS One. 2017;10:e0131999.
  • Ahmed S, Wang N, Lalonde M, et al. Green tea polyphenol epigallocatechin-3-gallate (EGCG) differentially inhibits interleukin-1 beta-induced expression of matrix metalloproteinase-1 and -13 in human chondrocytes. J Pharmacol Exp Ther. 2004;308:767–773.
  • Adikesavan G, Vinayagam MM, Abdulrahman LA, et al. (-)-Epigallocatechin-gallate (EGCG) stabilize the mitochondrial enzymes and inhibits the apoptosis in cigarette smoke-induced myocardial dysfunction in rats. Mol Biol Rep. 2013;40:6533–6545.10.1007/s11033-013-2673-5
  • Albrecht DS, Clubbs EA, Ferruzzi M, et al. Epigallocatechin-3-gallate (EGCG) inhibits PC-3 prostate cancer cell proliferation via MEK-independent ERK1/2 activation. Chem Biol Interact. 2008;171:89–95.10.1016/j.cbi.2007.09.001
  • Cai j, Jing D, Shi M, et al. Epigallocatechin gallate (EGCG) attenuates infrasound-induced neuronal impairment by inhibiting microglia-mediated inflammation, J Nutr Biochem. 2014;25;716–725.10.1016/j.jnutbio.2014.02.012
  • Mah YJ, Song JS, Kim SO, et al. The effect of epigallocatechin-3-gallate (EGCG) on human alveolar bone cells both in vitro and in vivo. Arch Oral Biol. 2014;59:539–549.10.1016/j.archoralbio.2014.02.011
  • Jin P, Wu H, Xu G, et al. Epigallocatechin-3-gallate (EGCG) as a pro-osteogenic agent to enhance osteogenic differentiation of mesenchymal stem cells from human bone marrow: an in vitro study. Cell Tissue Res. 2014;356:381–390.10.1007/s00441-014-1797-9
  • Song JE, Lee SE, Cha SR, et al. Inflammatory response study of gellan gum impregnated duck’s feet derived collagen sponges. J Biomater Sci Polym Ed. 2016;27:1495–1506.10.1080/09205063.2016.1213218
  • de Almeida OM, Jorgetti W, Oksman D, et al. Comparative study and histomorphometric analysis of bone allografts lyophilized and sterilized by autoclaving, gamma irradiation and ethylene oxide in rats. Acta Cir Bras. 2013;28:66–71.10.1590/S0102-86502013000100011
  • Boskey A, Pleshko Camacho N. FT-IR imaging of native and tissue-engineered bone and cartilage. Biomaterials. 2007;28:2465–2478.10.1016/j.biomaterials.2006.11.043
  • Pati F, Song TH, Rijal G. Ornamenting 3D printed scaffolds with cell-laid extracellular matrix for bone tissue regeneration. Biomaterials. 2015;37:230–241.10.1016/j.biomaterials.2014.10.012
  • Qin Y, Wang L, Gao Z. Bone marrow stromal/stem cell-derived extracellular vesicles regulate osteoblast activity and differentiation in vitro and promote bone regeneration in vivo. Sci Rep. 2016;6:21961.10.1038/srep21961
  • Boonrungsiman S, Gentleman E, Carzaniga R, et al. The role of intracellular calcium phosphate in osteoblast-mediated bone apatite formation. Proc Natl Acad Sci USA. 2012;109;14170–14175.
  • Tominari T, Matsumoto C, Watanabe K, et al. Epigallocatechin gallate (EGCG) suppresses lipopolysaccharide-induced inflammatory bone resorption, and protects against alveolar bone loss in mice. FEBS Open Bio. 2015;5:522–527.10.1016/j.fob.2015.06.003
  • Jeon OH, Panicker LM, Lu Q. Human iPSC-derived osteoblasts and osteoclasts together promote bone regeneration in 3D biomaterials. Sci Rep. 2016;6:1–11.
  • Vali B, Rao LG, El-Sohemy A. Epigallocatechin-3-gallate increases the formation of mineralized bone nodules by human osteoblast-like cells. J Nutr Biochem. 2007;18 (5):341–347.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.